Offer - Urjas Oil for just ₹ 1 X
Navelbine 10 Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Non-Small Cell Lung Cancer. The alternative uses of Navelbine 10 Injection have also been explained below.
The right dosage of Navelbine 10 Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Navelbine 10 Injection as well, which are listed below. Normally, these side effects of Navelbine 10 Injection are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Navelbine 10 Injection's effect during pregnancy is Severe and Severe while nursing. Further, the section on Navelbine 10 Injection related warnings talks about Navelbine 10 Injection's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Navelbine 10 Injection contraindications section.
Drug interactions for Navelbine 10 Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Navelbine 10 Injection is considered safe while driving, and is addictive.
Navelbine 10 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Adult(Female) |
|
Geriatric |
|
Is the use of Navelbine 10 Injection safe for pregnant women?
Navelbine has many dangerous side effects in pregnant women. If you are pregnant, do not consume Navelbine without medical advice.
Is the use of Navelbine 10 Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Navelbine. So it is adviced to consult the doctor before using it.
What is the effect of Navelbine 10 Injection on the Kidneys?
Navelbine is completely safe for kidneys.
What is the effect of Navelbine 10 Injection on the Liver?
You may experience side effects on your liver after taking Navelbine. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Navelbine 10 Injection on the Heart?
Navelbine is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Navelbine 10 Injection unless your doctor advises you to do so -
Is this Navelbine 10 Injection habit forming or addictive?
Forming a habit of Navelbine 10 Injection has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Navelbine 10 Injection since it will not make you feel sleepy.
Is it safe?
No, Navelbine 10 Injection is not completely safe as it has some side effects.
Is it able to treat mental disorders?
No, Navelbine 10 Injection is not used to treat mental disorders.
Interaction between Food and Navelbine 10 Injection
Taking Navelbine 10 Injection with food does not cause any problems.
Interaction between Alcohol and Navelbine 10 Injection
Due to lack of research, there is no information about the side effects of taking Navelbine 10 Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Navelbine (vinorelbine tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 865
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1271-1273